Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metvix PDT with laser vs conventional methods for actinic keratoses
NCT05456334Unknown
- Sponsor
- Helsinki University Hospital
- Start
- Mar 2016
- Primary completion
- Dec 2023
- Modality
- Light/Condition-Responsive Prodrugs
01
Overview
Randomised, single-blind trial of methyl aminolevulinate in actinic keratosis (AK) (4 arms), sponsored by Helsinki University Hospital. Primary endpoints: Patient complete or partial clearance at 2 years and Lesion-specific clearance at 2 years. Status: unknown.
02
Drugs
methyl aminolevulinate
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT05456334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05456334.